A detailed history of Lpl Financial LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 13,310 shares of CRDL stock, worth $17,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,310
Holding current value
$17,036
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.83 - $2.48 $24,357 - $33,008
13,310 New
13,310 $26,000
Q2 2022

Aug 12, 2022

BUY
$1.03 - $2.05 $10,536 - $20,971
10,230 New
10,230 $14,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $79.3M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.